Literature DB >> 10521732

Universal versus selective gestational diabetes screening: application of 1997 American Diabetes Association recommendations.

D R Danilenko-Dixon1, J T Van Winter, R L Nelson, P L Ogburn.   

Abstract

OBJECTIVE: We sought to evaluate the impact of the 1997 American Diabetes Association gestational diabetes mellitus screening guidelines applied to a universally screened population. STUDY
DESIGN: A retrospective analysis of 18,504 women universally screened for gestational diabetes mellitus at Mayo Clinic, Rochester, between January 1, 1986, and December 31, 1997, was performed. Diabetic screening consisted of plasma glucose determination 1 hour after a 50-g oral glucose challenge. Diagnosis of gestational diabetes mellitus was based on National Diabetes Data Group criteria.
RESULTS: Of 564 cases of gestational diabetes mellitus diagnosed during the study period, 17 (3.0%) would have been missed under the 1997 American Diabetes Association selective screening guidelines while exempting only 10% of this predominantly white population from screening. Screening only women >/=25 years old would have detected 90.4% of gestational diabetes mellitus cases, whereas the addition of the remaining 3 screening criteria combined would have detected only an additional 6.6% of cases.
CONCLUSIONS: The proportion of patients with gestational diabetes mellitus that would remain undiagnosed under the 1997 American Diabetes Association screening guidelines would be relatively small in our population. However, implementation of these guidelines would decrease the number of screens by only 10% while adding significant complexity to the screening process. Youth appears to be the most significant protective factor for gestational diabetes mellitus in our population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521732     DOI: 10.1016/s0002-9378(99)70304-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

Review 1.  The increasing prevalence of diabetes in pregnancy.

Authors:  Kelly J Hunt; Kelly L Schuller
Journal:  Obstet Gynecol Clin North Am       Date:  2007-06       Impact factor: 2.844

2.  Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial.

Authors:  M Ilkin Yeral; A Seval Ozgu-Erdinc; Dilek Uygur; K Doga Seckin; M Fatih Karsli; A Nuri Danisman
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

3.  Managing diabetes during pregnancy. Guide for family physicians.

Authors:  Ian P Sempowski; R L Houlden
Journal:  Can Fam Physician       Date:  2003-06       Impact factor: 3.275

4.  Counterpoint: Selective screening for gestational diabetes mellitus.

Authors:  Howard Berger; Mathew Sermer
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

5.  Maternal and fetal outcome of gestational diabetes mellitus in Mulago Hospital, Uganda.

Authors:  Emmanuel Odar; Julius Wandabwa; Paul Kiondo
Journal:  Afr Health Sci       Date:  2004-04       Impact factor: 0.927

6.  Point: Universal screening for gestational diabetes mellitus.

Authors:  Robert G Moses; N Wah Cheung
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

Review 7.  Risk factor screening to identify women requiring oral glucose tolerance testing to diagnose gestational diabetes: A systematic review and meta-analysis and analysis of two pregnancy cohorts.

Authors:  Diane Farrar; Mark Simmonds; Maria Bryant; Debbie A Lawlor; Fidelma Dunne; Derek Tuffnell; Trevor A Sheldon
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

8.  The prevalence of elevated high-sensitivity C-reactive protein in normal pregnancy and gestational diabetes mellitus.

Authors:  Renu Kumari; Harkaran Singh
Journal:  J Family Med Prim Care       Date:  2017 Apr-Jun

9.  Risk assessment does not explain high prevalence of gestational diabetes mellitus in a large group of Sardinian women.

Authors:  Cinzia Murgia; Rachele Berria; Luigi Minerba; Simonetta Sulis; Michela Murenu; Elaine Portoghese; Nicoletta Garau; Pierina Zedda; Gian Benedetto Melis
Journal:  Reprod Biol Endocrinol       Date:  2008-07-02       Impact factor: 5.211

10.  Screening uptake rates and the clinical and cost effectiveness of screening for gestational diabetes mellitus in primary versus secondary care: study protocol for a randomised controlled trial.

Authors:  Angela O'Dea; Jennifer J Infanti; Paddy Gillespie; Olga Tummon; Samuel Fanous; Liam G Glynn; Brian E McGuire; John Newell; Fidelma P Dunne
Journal:  Trials       Date:  2014-01-17       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.